Population PKPD of paclitaxel and carboplatin in ovarian cancer patients: A study by the EORTC-PAMM-NDDG |
| |
| Authors: | M. Joerger,A. D. R. Huitema,D. J. Richel,C. Dittrich,N. Pavlidis,E. Briasoulis,J. B. Vermorken,E. Strocchi,A. Martoni,R. Sorio,H. P. Sleeboom,M. A. Izquierdo,D. I. Jodrell,A. H. Calvert,A. Boddy,H. Hollema,R. Fé ty,W. J. F. Van der Vijgh,G. Hempel,E. Chatelut,M. Karlsson,B. Tranchand,A. H. G. J. Schrijvers,J. H. Beijnen,& J. H. M. Schellens |
| |
| Affiliation: | Department of Pharmacy &Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Amsterdam, The Netherlands,;Department of Medical Oncology, Antoni van Leeuwenhoek Hospital/The Netherlands Cancer Institute,;Division of Drug Toxicology, Department of Biomedical Analysis, Faculty of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands |
| |
| Abstract: | |
| |
| Keywords: | |
|
|
